New stroke pill shows promise in helping patients move again
Disease control
Completed
This study tested an oral medication called MLC1501 in 303 people who had a stroke within the past 2 to 10 days. Participants took either a high dose, low dose, or a placebo twice daily for 24 weeks. The main goal was to see if the drug improves motor skills, like moving arms and…
Phase: PHASE2 • Sponsor: Moleac Pte Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC